Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationCombined Modality TherapyAntigens, CD34Granulocyte Colony-Stimulating FactorMelphalanHematologic NeoplasmsMultiple MyelomaLeukapheresisCyclophosphamideStem CellsAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalBone Marrow TransplantationGraft SurvivalGraft vs Host DiseaseTreatment OutcomeHematopoietic Stem CellsMyeloablative AgonistsBusulfanEtoposideLymphoma, Non-HodgkinRemission InductionThiotepaRecurrenceAntineoplastic Agents, AlkylatingCarmustineSalvage TherapyCord Blood Stem Cell TransplantationCytophagocytosisTransplantation ChimeraIfosfamideHematopoiesisVincristineCytarabineDisease-Free SurvivalTissue DonorsAmyloidosisHodgkin DiseaseRetrospective StudiesWhole-Body IrradiationSurvival RateNeoplasmsTime FactorsSurvival AnalysisHistocompatibilityInfectionHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcutePlatelet CountLiver TransplantationDoxorubicinLymphoma, T-CellEmbryonic Stem CellsMesenchymal Stem Cell TransplantationVidarabineTransplantation, IsogeneicLeukemiaPrednisoneFollow-Up StudiesAdult Stem CellsBone Marrow PurgingPOEMS SyndromeGraft vs Leukemia EffectCarboplatinDexamethasoneBlood Cell CountCytomegalovirus InfectionsAntineoplastic AgentsBlood Transfusion, AutologousLymphomaRecombinant ProteinsFatal OutcomeProspective StudiesCell TransplantationFeasibility StudiesBlood CellsMyelodysplastic SyndromesPluripotent Stem CellsT-LymphocytesCell DifferentiationImmunophenotypingKidney TransplantationAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionHematologic DiseasesCell SeparationHLA AntigensFlow CytometryCells, CulturedPrognosisLeukocytes, MononuclearStem Cell Niche